Position in VCYT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,521,333
+$1,094,858 QoQ
Shares Held
59,958
-20.4% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
#6
of 67 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $26,693,573 across 9 Diagnostics & Research names. VCYT ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
40,605 | $11,022,227 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,106,468 | |
| 3 | VCYT |
Veracyte, Inc.
This page
|
59,958 | $3,521,333 | |
| 4 | PSNL |
Personalis, Inc.
|
239,000 | $3,202,600 | |
| 5 | NEO |
Neogenomics Inc
|
110,040 | $1,605,483 | |
| 6 | BDSX |
Biodesix Inc
|
44,618 | $1,006,135 | |
| 7 | MDXH |
MDxHealth SA
|
1,411,891 | $580,287 | |
| 8 | CSTL |
Castle Biosciences Inc
|
16,140 | $384,939 |
All Filings in VCYT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,521,333 | 59,958 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,426,475 | 75,333 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,175,729 | 75,433 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,735,517 | 79,683 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,215,108 | 81,950 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,566,207 | 86,550 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,571,920 | 90,200 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,197,377 | 93,930 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,141,646 | 98,830 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,570,116 | 115,980 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,223,621 | 117,180 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,672,454 | 119,680 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $3,090,275 | 121,330 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,717,924 | 121,880 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,919,501 | 123,030 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,050,598 | 123,530 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,549,787 | 128,130 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,390,558 | 122,980 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $5,097,676 | 123,730 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,805,321 | 124,980 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $4,996,700 | 124,980 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $6,798,300 | 126,480 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $6,219,295 | 127,080 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $4,242,544 | 130,580 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $2,959,256 | 121,730 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||